BiopharmIQ
Catalyst Calendar
Big Movers™
All Big Movers™
Current Qtr Report
Future Movers Report
Historical Movers Data
PDUFA Events
PDUFA Calendar
Current PDUFA Report
Historical PDUFA Report
Company Screener
M&A Activity
Historical M&A Data
M&A Target Ideas
Meeting Calendar
Hedge Funds
Fund Screener
All Ticker Holdings
Ticker Holdings by Size
Holdings Download
Analysts & Portfolios

Biotech ChatroomMy WatchlistsMy Notes
Try Elite FreeAlready have an account? Login

Enterprise Value

-111.8M

Cash

184.7M

Avg Qtr Burn

-25.39M

Short % of Float

3.64%

Insider Ownership

0.21%

Institutional Own.

-

Qtr Updated

06/30/23


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
KIN-7136 (MEK inhibitor) +/- exarafenib Details
Solid tumor/s, Non-small cell lung carcinoma

Phase 1

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
KIN-3248 (pan-FGFR inhibitor) Details
Cancer

Phase 1

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
exarafenib (KN-2787) +/- binimetinib Details
Cancer, Solid tumor/s, Melanoma

Phase 1

Update

Some catalyst date

You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.